8-K

AVAI BIO, INC. (AVAI)

8-K 2026-02-09 For: 2026-02-03
View Original
Added on April 10, 2026

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The SecuritiesExchange Act of 1934

Date of Report (Date of earliest event reported): February

3, 2026

AVAIBIO, INC.

(Exact name of registrant as specified in its charter)


AVANT TECHNOLOGIES INC.

(Former name or former address, if changed since last report.)

Nevada<br><br> <br>(State or other jurisdiction of incorporation<br> or organization) 333-225433<br><br> <br>(Commission File Number) 38-4053064<br><br> <br>(I.R.S. Employer Identification Number)



c/o Eastbiz.com, Inc 5348 Vegas Drive, Las Vegas,NV 89108


(Address and telephone number of principal executive offices)

(Issuer’s telephone number)

(866) 533-0065

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act: Not applicable.

Title of each class Trading Symbol Name of each exchange on which registered
Not applicable

Item 8.01 Other Events.

On February 3, 2026, Avant Technologies, Inc., a Nevada corporation (the “Company”) filed a Certificate of Amendment of its Articles of Incorporation with the Secretary of State of the State of Nevada to change the name of the Company to Avaí Bio, Inc. The Company’s ticker symbol will remain “AVAI.”

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
10.1 Certificate of Amendment to the Articles of Incorporation of Avant Technologies, Inc. (filed with the State of Nevada on February 3, 2026).

SIGNATURES


In accordance with the requirements of the Securities Act of 1933, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 9, 2026 AVANT TECHNOLOGIES INC.
By: /s/ Vitalis Racius
Name: Vitalis Racius
Title: Chief Financial Officer, Director & Treasurer

Ex 10.1